When IRB Is Reviewing a Research Study: What to Expect and How to Prepare

An Institutional Review Board (IRB) reviews research studies that involve human participants to protect their rights and welfare. If your study involves collecting data from people through surveys, interviews, biological samples, or medical interventions, you will likely need IRB approval before you begin. This article explains what happens during IRB review, what reviewers look for, and how you can prepare a submission that moves through the process efficiently.

What an IRB Does and Why It Exists

The IRB operates under federal guidelines with a clear mission to protect the rights and welfare of human subjects participating in research. This mandate shapes every decision the board makes. When you submit a protocol, the board evaluates whether your study design is sound, whether risks to participants are minimized and reasonable relative to potential benefits, and whether informed consent is adequate.

Understanding this mission helps you frame your application. The IRB is not a bureaucratic hurdle designed to slow your work. It is a safeguard that exists because research involving humans carries inherent risks, and participants deserve protection. The board's primary loyalty is to the people who volunteer for your study, not to your research goals.

The scope of IRB oversight extends beyond traditional medical trials. Pharmacy-related research, nursing studies, social science surveys, and quality improvement projects may all require IRB review depending on how they are designed and what you intend to do with the data. The key distinction often comes down to whether your activity constitutes research, meaning a systematic investigation designed to produce generalizable knowledge, or whether it is routine practice such as quality improvement. Practical guidance from the literature emphasizes that researchers who understand the criteria IRBs use and how those criteria may be interpreted can avoid deferrals or lengthy requests for protocol modifications or clarifications. When you anticipate potential IRB concerns and address them in your initial submission, you reduce the likelihood of back-and-forth correspondence. The PubMed record for Understanding institutional review boards describes these central requirements and offers specific suggestions for preparing applications that anticipate and address potential IRB concerns.

At a Glance: IRB Review Categories and What They Mean

The category assigned to your study depends on the level of risk and the specific procedures involved. You do not choose your category. The IRB makes that determination based on federal criteria and your submitted materials. However, understanding the categories helps you anticipate the timeline and the depth of review your protocol will receive. The Hospital Pharmacy article on navigating the IRB process discusses different categories of IRB submission and practical considerations for submitting applications and documentation.

Core Principles That Guide IRB Decisions

Risk Minimization and Reasonable Risk-Benefit Balance

The IRB evaluates whether the risks to participants are minimized through sound study design and whether those risks are reasonable in relation to the knowledge the study might produce. This means you need to demonstrate that you have thought carefully about potential harms and taken steps to reduce them.

For example, if you are collecting sensitive information through interviews, you should describe how you will protect confidentiality, where data will be stored, who will have access, and how identifiers will be handled. If you are drawing blood samples, you should describe the volume, frequency, and qualifications of the person performing the procedure. The Nutrition in Clinical Practice guidance describes the central requirements for IRB approval and core considerations of IRBs, including how researchers can prepare applications to anticipate and address potential IRB concerns.

Informed Consent

Informed consent is a central requirement for most research involving humans. Participants must understand what they are being asked to do, what risks they face, what benefits might exist, and that they can withdraw at any time without penalty. Your consent document must be written in language that your participant population can understand.

The IRB reviews your consent process beyond the consent form. You should describe how consent will be obtained, who will obtain it, and what steps you will take to ensure participants understand the information. For studies involving children, prisoners, pregnant women, or other vulnerable populations, additional protections apply. The Hospital Pharmacy article discusses informed consent and conditions for waivers or alterations of consent as key considerations in the IRB process.

Equitable Participant Selection

The IRB considers who you are recruiting and whether that selection is fair. You should justify your inclusion and exclusion criteria. If you are excluding certain groups, explain why. If you are including vulnerable populations, explain why their participation is necessary and what additional safeguards you have in place.

Preparing Your IRB Submission

Start With a Complete Protocol

The protocol is the foundation of your submission. It should describe your research question, background and significance, study design, participant population, recruitment methods, data collection procedures, data analysis plan, and plans for protecting participants. A well-written protocol demonstrates that you have thought through the scientific and ethical dimensions of your study.

The Nephrology Nursing Journal article on navigating the IRB process provides basic information related to the IRB process and steps to follow in the preparation and submission of a research project for IRB approval. Before undertaking any aspect of a research project that involves human participants, the principal investigator must submit the project to and gain approval from an IRB.

Gather All Required Documents

Most IRB submissions require more than the protocol. You will typically need:

• A completed application form specific to your institution
• The research protocol or study plan
• Informed consent documents
• Recruitment materials such as flyers, emails, or scripts
• Data collection instruments such as surveys or interview guides
• Any relevant approvals from other committees, such as radiation safety or biosafety
• Documentation of investigator qualifications and training in human subjects protection

Check your institution's IRB website for the specific requirements. Missing documents are a common reason for delays. The Hospital Pharmacy article outlines practical considerations for submitting IRB applications and documentation, noting that researchers should account for organization-specific IRB processes when designing, submitting, and implementing research projects.

Write for the Reader

IRB members come from diverse backgrounds. Some are scientists, some are nonscientists, and some are community members. Your application should be understandable to all of them. Avoid jargon where possible, define technical terms, and explain why your study matters.

The literature on IRB processes consistently notes that clear communication reduces review time. A machine learning analysis of IRB processing times identified several predictors of delays in IRB protocol review processing times, including the type of IRB review to be conducted and specific staff in charge of a protocol's review. While you cannot control all of these factors, you can control the clarity and completeness of your submission. The analysis also showed that applying knowledge about predictors of delays to process improvement efforts in two IRBs led to increased efficiency in protocol review.

The Submission and Review Workflow

Submit Through the Proper Channel

Most institutions now use electronic submission systems. Create your account early, familiarize yourself with the system, and ensure you have all required fields completed before you submit. Incomplete submissions are often returned without review.

Track Your Application

After submission, your application enters a queue. The time to a decision varies based on the review category, the workload of the IRB, and the completeness of your submission. Some institutions provide status updates through their electronic system. Check regularly and respond promptly to any requests for additional information.

Respond to Requests for Revisions

It is common for IRBs to request modifications or clarifications. This is not a rejection. The board is telling you what needs to change before approval can be granted. Read the requests carefully, address each point, and resubmit promptly.

Common revision requests include:

• Clarifying the consent process
• Revising consent language to be more understandable
• Adding safeguards for data security
• Justifying inclusion or exclusion criteria
• Providing additional information about study procedures

The Nutrition in Clinical Practice guidance notes that when researchers are familiar with IRB criteria and how they may be interpreted, they can avoid deferrals or lengthy requests for protocol modifications or clarifications. General tips regarding the preparation of IRB submission materials may allow for a smoother IRB review process.

Options and Tradeoffs in Study Design

Quality Improvement Versus Research

One of the most common questions researchers face is whether their project requires IRB review at all. The distinction between quality improvement and research matters because quality improvement activities typically do not require IRB approval, while research does.

Quality improvement focuses on improving local practices and uses data for internal purposes. Research aims to produce generalizable knowledge that can be applied beyond the local setting. The key question is your intent and how you plan to use the data. If you intend to publish findings or present them as generalizable knowledge, your project likely constitutes research. The Hospital Pharmacy article discusses key distinctions between quality improvement and research as a practical consideration for IRB processes.

Single IRB Review for Multisite Studies

If your study involves multiple sites, the revised Common Rule requires using a single institutional review board for U.S.-based, multisite, nonexempt, federally conducted or supported research with human participants. Stakeholder experiences with single IRB review have identified both benefits and challenges.

Benefits include consistency and standardization across sites, speed and efficiency, and streamlined processes. Challenges include uncertainty at local institutions, addressing local context, variable processes, and insufficient communication. The Ethics and Human Research stakeholder study found that the main benefits of single IRB review were consistency and standardization, speed and efficiency, and streamlining and simplification. The main challenges were uncertainty at local institutions, including addressing local context, decreased timeliness of the research review process, variable processes, and insufficient communication. If you are planning a multisite study, you should understand how the single IRB arrangement will work and what your responsibilities are to the reviewing IRB and to your local institution.

Exempt and Expedited Categories

Not all research requires full board review. Exempt categories apply to minimal risk studies that fit specific federal criteria, such as surveys with no identifiers or educational tests. Expedited review applies to minimal risk studies that fit other specific categories, such as collection of blood samples by finger stick or routine clinical data.

Even if your study qualifies for exempt or expedited review, you still submit materials and receive a determination. The difference is in the depth of review and the timeline. The Hospital Pharmacy article discusses different categories of IRB submission and the overarching mission of the IRB overseeing research at an organization per federal guidelines, which is to protect the rights and welfare of human subjects participating in research.

Records and Measurements You Should Maintain

Documentation of the Approval Process

Keep copies of everything you submit to the IRB and everything the IRB sends to you. This includes your initial application, the approval letter, any correspondence about revisions, and the final approved versions of your consent documents and protocols.

Documentation of Approved Materials

Once your study is approved, you must use the exact versions of consent forms, recruitment materials, and protocols that the IRB approved. If you need to change anything, you must submit an amendment and receive approval before implementing the change.

Documentation of Participant Interactions

Maintain records of participant enrollment, consent, and any adverse events or unanticipated problems. The IRB may require continuing review at specified intervals, and your records will be essential for demonstrating compliance. The Nephrology Nursing Journal article emphasizes that prior to undertaking any aspect of a research project that involves human participants, the principal investigator must submit the project to and gain approval from an IRB.

Common Failure Patterns in IRB Submissions

Incomplete Applications

The most common reason for delays is an incomplete application. Missing documents, unanswered questions, and vague descriptions all slow the process. Before submitting, review the application against the institution's checklist and ensure every item is addressed.

Vague or Contradictory Information

IRB members need to understand exactly what participants will experience. If your protocol says one thing and your consent form says another, the board will flag the discrepancy. Review all documents for consistency before submission.

Inadequate Consent Language

Consent forms that are too long, too technical, or too legalistic fail to serve their purpose. Participants need to understand what they are agreeing to. Write consent documents in plain language and test them with people who are not part of your research team.

Failure to Address Data Security

IRBs pay close attention to how you will protect participant data. Describe your storage methods, encryption practices, access controls, and plans for data destruction. Vague statements about keeping data secure are not sufficient.

Ignoring Local Context

For multisite studies, the single IRB must consider local context at each site. The stakeholder study on single IRB review highlighted that uncertainty at local institutions and insufficient communication are common challenges. If you are working with multiple sites, ensure that local considerations are addressed in your submission.

Limitations of the IRB Process

IRBs Cannot Guarantee Scientific Validity

The IRB reviews the ethics of your study, including whether the science is sound enough to justify involving human participants. However, the board is not a substitute for rigorous scientific peer review. You remain responsible for the quality of your research design. The Pan African Medical Journal article on ethics approval responsibilities notes that for a study to be ethically sound, it must be scientifically sound, and this is only one of the activities carried out during protocol review.

IRB Review Does Not Eliminate Risk

Approval means the IRB has determined that risks are minimized and reasonable. It does not mean your study is risk-free. You must continue to monitor for adverse events and report unanticipated problems to the IRB.

Institutional Variation Exists

While federal regulations provide a common framework, individual institutions implement IRB processes differently. Your institution may have additional requirements beyond the federal minimums. Familiarize yourself with your local IRB's specific procedures and expectations. The Hospital Pharmacy article notes that researchers should account for organization-specific IRB processes when designing, submitting, and implementing research projects.

Safety and Regulatory Context

Federal Regulations and the Common Rule

The Common Rule sets the federal requirements for protecting human subjects in research. It applies to research conducted or supported by federal agencies. Understanding the Common Rule helps you anticipate what your IRB will require. The stakeholder study on single IRB review notes that the revised Common Rule requires using a single IRB for U.S.-based, multisite, nonexempt, federally conducted or supported research with human participants.

Vulnerable Population Protections

Research involving children, prisoners, pregnant women, fetuses, neonates, or individuals with impaired decision-making capacity triggers additional regulatory requirements. If your study includes any of these populations, you must describe the additional safeguards you will implement.

Reporting Requirements

You have ongoing obligations after approval. Adverse events, unanticipated problems involving risks to participants, and protocol deviations must be reported to the IRB according to your institution's policies. Failure to report can result in suspension of your study.

Professional Escalation Criteria

When to Contact the IRB Directly

If you are uncertain about whether your project requires IRB review, contact the IRB office before you begin. It is better to ask than to proceed without approval and later discover you violated regulations. The Pan African Medical Journal article emphasizes that the researcher has the responsibility of systematically consulting the competent ethics committee for advice and consequent approvals or ethical waivers.

When to Seek Institutional Support

If your study involves complex regulatory requirements, vulnerable populations, or sensitive data, consider seeking guidance from your institution's research office or regulatory specialists. They can help you navigate the process and avoid common pitfalls.

When to Consult Legal or Compliance Experts

If your study involves FDA-regulated products, international research, or other high-risk areas, you may need specialized expertise beyond what the IRB office provides. Consult with your institution's compliance office or legal counsel as appropriate.

Practical Steps for a Smooth IRB Review

Step 1: Determine Whether IRB Review Is Required

Before designing your study, determine whether it constitutes research involving human subjects. If you are uncertain, contact your IRB office for a determination. The Nephrology Nursing Journal article provides steps to follow in the preparation and submission of a research project for IRB approval.

Step 2: Design Your Study With Ethics in Mind

Build ethical considerations into your study design from the beginning. Think about risk minimization, consent procedures, data security, and equitable participant selection as you develop your protocol.

Step 3: Review the Literature and Reporting Standards

Familiarize yourself with reporting guidelines relevant to your study type. The EQUATOR Network provides resources for health research reporting standards. Consulting these resources can help you design a study that meets scientific and ethical expectations.

Step 4: Use Available Tools for Study Design

The NC3Rs Experimental Design Assistant is a tool that helps researchers design rigorous animal studies. While it is designed for animal research, the principles of careful experimental design apply to human research as well. A well-designed study is easier to justify to an IRB.

Step 5: Prepare Your Submission Package

Gather all required documents, write your protocol, draft consent materials, and complete the application form. Review everything for completeness and consistency before submitting.

Step 6: Submit and Track

Submit through the proper channel and monitor the status of your application. Respond promptly to any requests for additional information.

Step 7: Maintain Compliance After Approval

Once approved, follow your approved protocol exactly. Submit amendments for any changes, report adverse events promptly, and maintain complete records.

Frequently Asked Questions

What is the purpose of an IRB in a federally supported research study?

The IRB protects the rights and welfare of human subjects participating in research. For federally supported studies, the Common Rule requires IRB review to ensure that risks are minimized, informed consent is adequate, and participant selection is equitable. The board serves as an independent check on the researcher to ensure that the interests of participants are protected. The Hospital Pharmacy article describes the overarching mission of the IRB overseeing research at an organization per federal guidelines as protecting the rights and welfare of human subjects participating in research.

Who are considered participants in a research study?

Participants are the individuals whose data or biological materials you collect and use for your research. This includes people who complete surveys, participate in interviews, undergo study procedures, or provide samples. Even if you are using existing data or specimens, the individuals from whom that data or material came are considered participants.

How long does IRB review take?

The timeline varies based on the review category and the workload of the IRB. Exempt and expedited reviews typically take less time than full board reviews. The completeness and clarity of your submission also affect the timeline. Incomplete applications or requests for revisions add time to the process. The machine learning analysis of IRB processing times identified several predictors of delays in IRB protocol review processing times, including type of IRB review to be conducted and specific staff in charge of a protocol's review.

What happens if my study is not approved?

If the IRB does not approve your study, you will receive feedback explaining the reasons. You can revise your protocol and resubmit. The IRB is not rejecting you personally. It is identifying issues that need to be addressed before the study can proceed ethically. The Nutrition in Clinical Practice guidance notes that researchers who are familiar with IRB criteria and how they may be interpreted can avoid deferrals or lengthy requests for protocol modifications or clarifications.

Can I start my research before I receive IRB approval?

No. You must receive IRB approval before you begin any research activities involving human participants. This includes recruitment, data collection, and even pilot testing. Starting before approval is a serious violation of research regulations. The Nephrology Nursing Journal article emphasizes that prior to undertaking any aspect of a research project that involves human participants, the principal investigator must submit the project to and gain approval from an IRB.

Do I need IRB approval for a quality improvement project?

It depends on the nature of the project and your intent. Quality improvement activities that are designed to improve local practices and are not intended to produce generalizable knowledge typically do not require IRB approval. However, if you plan to publish or present your findings as generalizable knowledge, your project may constitute research and require IRB review. The Hospital Pharmacy article discusses key distinctions between quality improvement and research as a practical consideration for IRB processes.

What should I do if my approved study changes?

Submit an amendment to the IRB before implementing any changes to your approved protocol. This includes changes to study procedures, consent forms, recruitment materials, or personnel. The IRB must approve the changes before you implement them.

What are my reporting obligations after approval?

You must report adverse events, unanticipated problems involving risks to participants, and protocol deviations to the IRB according to your institution's policies. You may also be required to submit continuing review materials at specified intervals. Check your approval letter for the specific requirements that apply to your study.

Related Articles

• Multiple Sequence Alignment: Common Pitfalls and Quality Checks
• Bioinformatics PhD Applications: Planning the Research Fit Process
• Responding to Peer Review: A Structured Revision and Response Process
• Research Authorship: Discussing Credit, Contributions, and Order Before Submission
• Circulation Research

References and Further Reading

• Research Data Framework. National Institute of Standards and Technology.
• EQUATOR Network. EQUATOR Network.
• Experimental Design Assistant. NC3Rs.
• NCBI Literature Resources. National Center for Biotechnology Information.
• PubMed. National Library of Medicine.
• Recommendations to the IRB review process in preparation of xenotransplantation clinical trials.. Xenotransplantation, 2020.
• Understanding institutional review boards: practical guidance to the IRB review process.. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2007.
• Chloroplast immunophilins.. Protoplasma, 2016.
• Navigating the Institutional Review Board (IRB) Process for Pharmacy-Related Research.. Hospital pharmacy, 2017.
• IRB Process Improvements: A Machine Learning Analysis.. Journal of clinical and translational science, 2017.
• Navigating the Institutional Review Board Process.. Nephrology nursing journal : journal of the American Nephrology Nurses' Association, 2022.
• Visual memory.. Attention, perception & psychophysics, 2026.
• Stakeholder Experiences with the Single IRB Review Process and Recommendations for Food and Drug Administration Guidance.. Ethics & human research, 2021.
• Special Considerations for Navigating the Institutional Review Board Process.. 2026.
• Embracing research ethics approval: from cognitive walk-through to reflexive journey. 2020.
• Ethics approval: responsibilities of journal editors, authors and research ethics committees. The Pan African Medical Journal, 2017.
• Applying for animal research ethics approval - Current Students. 2018.
• Maintaining your animal research ethics approval - Current Students. 2018.
• Enhancing post-incident reviews through Incident Review Board (IRB) process. International Petroleum Technology Conference 2011 Iptc 2011, 2011.
• Enhancing post-incident reviews through Incident Review Board (IRB) process. Society of Petroleum Engineers International Petroleum Technology Conference 2012 Iptc 2012, 2012.

This article is educational and does not replace institutional policy, professional advice, or applicable safety and regulatory requirements.